(Q34175396)

31 July 2017

1 reference

title

New insights in insurmountable antagonism (English)

1 reference

31 July 2017

Vauquelin G

1

1 reference

31 July 2017

Van Liefde I

series ordinal

2

1 reference

31 July 2017

Birzbier BB

series ordinal

3

1 reference

31 July 2017

Vanderheyden PM

series ordinal

4

1 reference

31 July 2017

1 August 2002

1 reference

Fundamental and Clinical Pharmacology

31 July 2017

1 reference

31 July 2017

16

1 reference

31 July 2017

263-272

1 reference

31 July 2017

4

1 reference

Quantitative studies of antagonists for 5-hydroxytryptamine

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Effect of omeprazole on gastric acid secretion by the rat isolated stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Allosteric interactions at muscarinic cholinoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Characterization of alpha 1-adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Cardiac and gastric effects of histamine H2 receptor antagonists: no evidence for a correlation between lipophilicity and receptor affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Allosteric properties of 5-HT2 receptors in tracheal smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Insurmountable AT(1) receptor antagonism: the need for different antagonist binding states of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Agonist-antagonist interactions at angiotensin receptors: application of a two-state receptor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Partial agonists and G protein-coupled receptor desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Agonist-induced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

The classification of 5-hydroxytryptamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

An analysis of 5-hydroxytryptamine receptors mediating contraction of isolated smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Effect of nepadutant at tachykinin NK(2) receptors in human intestine and urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

In vivo apparent affinity and efficacy estimates for mu opiates in a rat tail-withdrawal assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Analysis of Apparent Noncompetitive Responses to Competitive H(1)-Histamine Receptor Antagonists in Fluorescent Imaging Plate Reader-Based Calcium Assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Dynamic mechanisms of non-classical antagonism by competitive AT(1) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

The cholecystokinin-B receptor antagonist L-740,093 produces an insurmountable antagonism of CCK-4 stimulated functional response in cells expressing the human CCK-B receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Mechanisms of intron mobility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

From 'captive' agonism to insurmountable antagonism: demonstrating the power of analytical pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Pseudo-noncompetitive antagonism by BQ123 of intracellular calcium transients mediated by human ETA endothelin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Regulated expression of the rat recombinant P2X(3) receptor in stably transfected CHO-K1 tTA cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Competitive and non competitive interactions of BQ-123 with endothelin ETA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Pharmacologic profiles of KRH-594, a novel nonpeptide angiotensin II-receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Non-competitive pharmacological antagonism at the rabbit B(1) receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Allosteric antagonists of the muscarinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Proteins and DNA in systematic biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Concentration-effect relationships with FM 24: a new long acting beta- adrenergic receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

Significance of angiotensin type 1 receptor blockade: why are angiotensin II receptor blockers different?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2002.00095.X

10.1046/J.1472-8206.2002.00095.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference